Cargando…

Do we still need to do dual tracer localisation for sentinel node biopsy in patients with early breast cancer?

Detalles Bibliográficos
Autores principales:	Najeeb, Erum, Verroiotou, Maria, Ramzi, Saed, Simonca, Claudiu, Jenkins, Stephanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833842/ http://dx.doi.org/10.1016/j.ejso.2020.11.096

Ejemplares similares

A study demonstrating the accuracy of a new triage system for breast cancer referrals during the Covid-19 pandemic in a tertiary hospital.
por: Goh, Ngee-Ming, et al.
Publicado: (2021)

A Study Evaluating the Accuracy of Triage for Breast Referrals During the Covid-19 Pandemic in a Tertiary Hospital
por: Goh, Ngee-Ming, et al.
Publicado: (2023)

Redefining Criteria to Ensure Adequate Sentinel Lymph Node Biopsy With Dual Tracer for Breast Cancer
por: Xu, Li, et al.
Publicado: (2020)

Do we still need renal biopsy in lupus nephritis?
por: Haładyj, Ewa, et al.
Publicado: (2016)

Accuracy of Sentinel Lymph Node Biopsy in Breast Cancer: Pitfalls in the Application of Single Tracers
por: Yang, Jiqiao, et al.
Publicado: (2020)

The Clinical Usefulness of the Sentinel Lymph Node in Rectal Cancer: Do We Believe It?
por: Kim, Jong Woo
Publicado: (2011)

Comparison of three magnetic nanoparticle tracers for sentinel lymph node biopsy in an in vivo porcine model
por: Pouw, Joost J, et al.
Publicado: (2015)

Acral Lentiginous Melanoma: Do Surgical Approach and Sentinel Lymph Node Biopsy Matter?
por: Walker, Marc E., et al.
Publicado: (2020)

Sentinel Lymph Node Biopsy in Endometrial Cancer: Dual Injection, Dual Tracer—A Multidisciplinary Exhaustive Approach to Nodal Staging
por: Torrent, Anna, et al.
Publicado: (2022)

Do we still need supertrees?
por: Haeseler, Arndt von
Publicado: (2012)

Feasibility of Sentinel Node Biopsy in Head and Neck Melanoma Using a Hybrid Radioactive and Fluorescent Tracer
por: Brouwer, Oscar R., et al.
Publicado: (2011)

Nanocarbon Tracer and Areola Injection Site Are Superior in the Sentinel Lymph Node Biopsy Procedure for Breast Cancer
por: Song, Bo, et al.
Publicado: (2022)

Tilmanocept as a novel tracer for lymphatic mapping and sentinel lymph node biopsy in melanoma and oral cancer
por: Mwagiru, Derek, et al.
Publicado: (2022)

Is blue dye still required during sentinel lymph node biopsy for breast cancer?
por: Peek, Mirjam CL, et al.
Publicado: (2016)

Development of novel tracers for sentinel node identification in cervical cancer
por: Kodama, Keisuke, et al.
Publicado: (2023)

The efficacy of (99m)Tc-rituximab as a tracer for sentinel lymph node biopsy in cutaneous melanoma patients
por: Liu, Jiayong, et al.
Publicado: (2022)

Retracted: Nanocarbon Tracer and Areola Injection Site Are Superior in the Sentinel Lymph Node Biopsy Procedure for Breast Cancer
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer: The GREENORBLUE Trial
por: Nguyen, Chu Luan, et al.
Publicado: (2023)

An evidence-based approach to positive sentinel node disease: should we ever do a completion node dissection?
por: Downs, Jennifer S, et al.
Publicado: (2019)

Feasibility of Real-Time Near-Infrared Fluorescence Tracer Imaging in Sentinel Node Biopsy for Oral Cavity Cancer Patients
por: Christensen, Anders, et al.
Publicado: (2015)

Application of fluorescence endoscopy with methylene blue dye and indocyanine green dual-tracer method in sentinel lymph node biopsy for women with breast cancer
por: Ou, Caifeng, et al.
Publicado: (2023)

Why do we still permit tobacco use?
por: Tiffin, Norman H
Publicado: (2015)

False-Negative Sentinel Node Biopsy
por: Nieweg, Omgo E.
Publicado: (2009)

Avoiding unnecessary sentinel node biopsy
por: Jeffree, JS, et al.
Publicado: (2006)

Clinical aspects of sentinel node biopsy
por: Cody, Hiram S
Publicado: (2001)

The Evolution of the Sentinel Node Biopsy in Melanoma
por: Allard-Coutu, Alexandra, et al.
Publicado: (2023)

Meta-Analysis of the Diagnostic Value of Tracer Staining Technology Based on Nanocarbon Suspension in Sentinel Lymph Node Biopsy of Breast Cancer
por: Xia, Luhua, et al.
Publicado: (2022)

Comparative observation of common tracers in sentinel lymph node biopsy of breast cancer and a study on simplifying its surgical procedure
por: Sun, Shuo, et al.
Publicado: (2023)

Breast Core Biopsy Information and Consent: Do we Prepare or do we Scare?
por: Pollard, Jennifer, et al.
Publicado: (2021)

The Role of PLA2R in Primary Membranous Nephropathy: Do We Still Need a Kidney Biopsy?
por: McDonnell, Thomas, et al.
Publicado: (2023)

Technetium-99m-labeled rituximab for use as a specific tracer of sentinel lymph node biopsy: a translational research study
por: Wang, Xuejuan, et al.
Publicado: (2016)

Comparisons of ICG-fluorescence with conventional tracers in sentinel lymph node biopsy for patients with early-stage breast cancer: A meta-analysis
por: Yin, Rui, et al.
Publicado: (2021)

Why do we still need participatory technology assessment?
por: Hennen, Leonhard
Publicado: (2012)

Do we still use Allopathy to indicate Modern medicine?
por: Mondal, Himel, et al.
Publicado: (2022)

MDS subclassification—do we still have to count blasts?
por: Huber, Sandra, et al.
Publicado: (2023)

Orthopoxvirus Zoonoses—Do We Still Remember and Are Ready to Fight?
por: Gieryńska, Małgorzata, et al.
Publicado: (2023)

Axillary management still needed for patients with sentinel node micrometastases
por: Cong, Bin-Bin, et al.
Publicado: (2019)

Sentinel node biopsy in early vulvar cancer
por: Cicco, C De, et al.
Publicado: (2000)

Cutaneous Melanoma and Sentinel Lymph Node Biopsy
por: van Akkooi, A. C. J., et al.
Publicado: (2008)

Sentinel lymph node biopsies in breast cancer
por: Hess, A, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_v3gn317gaa2pmrdr9p0vtpb68l